Phenome Health

Pilot type 2 diabetes study. In 2024 we continued a pilot study of type 2 diabetes that began in 2023. This study is enrolling 25 patients with diabetes, through clinical partnerships, in preparation for a 1000 person diabetes study for which funding is anticipated in q2 2025. The pilot study sought to test the all project infrastructure required to enroll patients, collect biological samples, and generate and analyze health dataas a proof of principle study. This study will close out at the launch of the larger study in 2025.

Multiomic data platform build. In 2024 we continued to invest in building a computational environment capable of serving the need to ingest and analyze high dimensional health data. This platform requires continued feature development and maintenance. It is currently serving existing predictive modeling needs and will serve projects we secure funding for in the future.